» Articles » PMID: 38008733

A 16-year-old Man with Leptospirosis and Atypical Disseminated Intravascular Coagulation: a Case Report

Overview
Journal J Med Case Rep
Publisher Biomed Central
Specialty General Medicine
Date 2023 Nov 26
PMID 38008733
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Leptospirosis is known for its pulmonary form characterized by intra-alveolar hemorrhage, exhibiting a high mortality rate. Management by venous-venous extracorporeal membrane oxygenation has been reported in a small number of cases.

Case Presentation: We report herein the case of a 16-year-old Caucasian male who was admitted with rapidly deteriorating respiratory and digestive complaints. He developed severe acute respiratory distress syndrome secondary to disseminated intravascular coagulation and intra-alveolar hemorrhage, requiring initiation of venous-venous extracorporeal membrane oxygenation. Initial infectious and immunological assessments were inconclusive, but repeat serology on the tenth day of admission confirmed a diagnosis of leptospirosis. The patient received multiple transfusions, and upon favorable response to treatment with corticosteroids and antibiotics, he was successfully weaned off venous-venous extracorporeal membrane oxygenation, which was discontinued after 12 days.

Conclusion: Leptospirosis is a rare cause of severe acute respiratory failure following pulmonary hemorrhage. It is typically diagnosed by serology, with detectable IgM antibodies 5-7 days after the onset of symptoms. We report that early support with respiratory extracorporeal membrane oxygenation favors timely clearance of endobronchial clotting, parenchymal recovery, and prevention of ventilator-induced lung injury. Major hypofibrinogenemia, which did not seem to worsen during extracorporeal membrane oxygenation application, was managed by repeated transfusions. Further studies investigating the pathogenesis of this coagulopathy are required to further optimize the management of this rare and severe complication.

References
1.
Fonseka C, Lekamwasam S . Role of Plasmapheresis and Extracorporeal Membrane Oxygenation in the Treatment of Leptospirosis Complicated with Pulmonary Hemorrhages. J Trop Med. 2019; 2018:4520185. PMC: 6304550. DOI: 10.1155/2018/4520185. View

2.
Azevedo A, Miranda-Filho D, Henriques-Filho G, Leite A, Ximenes R . Randomized controlled trial of pulse methyl prednisolone × placebo in treatment of pulmonary involvement associated with severe leptospirosis. [ISRCTN74625030]. BMC Infect Dis. 2011; 11:186. PMC: 3162901. DOI: 10.1186/1471-2334-11-186. View

3.
Paganin F, Bourdin A, Dalban C, Courtin J, Poubeau P, Borgherini G . Leptospirosis in Reunion Island (Indian Ocean): analysis of factors associated with severity in 147 confirmed cases. Intensive Care Med. 2007; 33(11):1959-66. DOI: 10.1007/s00134-007-0776-y. View

4.
Nicodemo A, Duarte-Neto A . Pathogenesis of Pulmonary Hemorrhagic Syndrome in Human Leptospirosis. Am J Trop Med Hyg. 2021; 104(6):1970-1972. PMC: 8176490. DOI: 10.4269/ajtmh.20-1000. View

5.
Lee N, Kitashoji E, Koizumi N, Lacuesta T, Ribo M, Dimaano E . Building prognostic models for adverse outcomes in a prospective cohort of hospitalised patients with acute leptospirosis infection in the Philippines. Trans R Soc Trop Med Hyg. 2018; 111(12):531-539. DOI: 10.1093/trstmh/try015. View